Latest filing published 16 Jan 2015 for Radius Health, Inc..
Insider track record
No signal scores available.
F2 Bioscience III, L.P.: trading record in brief
F2 Bioscience III, L.P. discloses dealings in Radius Health, Inc. to SEC (Form 4). In total, 3 filings cover trades dated from 6 June 2014 to 16 January 2015.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 16 January 2015, reports a transaction in Radius Health, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to F2 Bioscience III, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,167,997 sharesCommon StockSEC:0001104659-15-003028:0
- 389,331 sharesCommon StockSEC:0001104659-15-001881:0
- 1,557,328 sharesCommon StockSEC:0001104659-14-045184:0
3 of 3 declarations
